Media Summary: MindMed finds a promising comparison between LSD and psilocybin; Dr Alastair Riddell, Chief Operating Officer at Dr. David Erritzoe, Chief Investigator of

Psyc Highlights On Small Pharma - Detailed Analysis & Overview

MindMed finds a promising comparison between LSD and psilocybin; Dr Alastair Riddell, Chief Operating Officer at Dr. David Erritzoe, Chief Investigator of Cybin is on a mission to “revolutionize” mental healthcare, and CEO Doug Drysdale assures that mission statement is not just ... Join us as we look back on an unforgettable Software Psycheceutical, Inc., a biotechnology company targeting the development and commercialization of psychedelic medicines, ...

George Tziras, Chief Executive Officer, sat down to share more about what excites him most working at Dr. Carol Routledge, Chief Medical & Scientific Officer of Our Chief Medical & Scientific Officer Dr Carol Routledge, discusses some of the key Ellen James, Director of Research & Development, shares her excitement about the plans for Enveric Biosciences announced the closing of its acquisition of MagicMed Industries Inc. ("MagicMed"), a biotechnology company ...

Photo Gallery

$PSYC Highlights on Small Pharma
$PSYC Business Roundup | Clinical Trials w/ MindMed, Small Pharma, & Mydecine
$PSYC Highlights Featuring Mindset Pharma
Small Pharma's Big Minds  - Dr Alastair Riddell
Dr. David Erritzoe discusses the results from Small Pharma's SPL026 Phase IIa Study
Small Pharma's Big Minds - Alex Kelly
$PSYC Highlights On Cybin
Software Pharma Open 2025 – Enjoy the highlights
Small Pharma's Big Minds - Sarah Hamilton
$PSYC Highlights on Psycheceutical
Small Pharma's Big Minds - George Tziras, CEO
Nick’s Thoughts on Pharma Companies | Psychology Is Clips
Sponsored
Sponsored
View Detailed Profile
$PSYC Highlights on Small Pharma

$PSYC Highlights on Small Pharma

Small Pharma

$PSYC Business Roundup | Clinical Trials w/ MindMed, Small Pharma, & Mydecine

$PSYC Business Roundup | Clinical Trials w/ MindMed, Small Pharma, & Mydecine

MindMed finds a promising comparison between LSD and psilocybin;

Sponsored
$PSYC Highlights Featuring Mindset Pharma

$PSYC Highlights Featuring Mindset Pharma

MindSet

Small Pharma's Big Minds  - Dr Alastair Riddell

Small Pharma's Big Minds - Dr Alastair Riddell

Dr Alastair Riddell, Chief Operating Officer at

Dr. David Erritzoe discusses the results from Small Pharma's SPL026 Phase IIa Study

Dr. David Erritzoe discusses the results from Small Pharma's SPL026 Phase IIa Study

Dr. David Erritzoe, Chief Investigator of

Sponsored
Small Pharma's Big Minds - Alex Kelly

Small Pharma's Big Minds - Alex Kelly

Small Pharma's

$PSYC Highlights On Cybin

$PSYC Highlights On Cybin

Cybin is on a mission to “revolutionize” mental healthcare, and CEO Doug Drysdale assures that mission statement is not just ...

Software Pharma Open 2025 – Enjoy the highlights

Software Pharma Open 2025 – Enjoy the highlights

Join us as we look back on an unforgettable Software

Small Pharma's Big Minds - Sarah Hamilton

Small Pharma's Big Minds - Sarah Hamilton

Small Pharma's

$PSYC Highlights on Psycheceutical

$PSYC Highlights on Psycheceutical

Psycheceutical, Inc., a biotechnology company targeting the development and commercialization of psychedelic medicines, ...

Small Pharma's Big Minds - George Tziras, CEO

Small Pharma's Big Minds - George Tziras, CEO

George Tziras, Chief Executive Officer, sat down to share more about what excites him most working at

Nick’s Thoughts on Pharma Companies | Psychology Is Clips

Nick’s Thoughts on Pharma Companies | Psychology Is Clips

From

Small Pharma

Small Pharma

Small Pharma

What is deuteration? Small Pharma’s Phase I trial with SPL028 - Dr Carol Routledge

What is deuteration? Small Pharma’s Phase I trial with SPL028 - Dr Carol Routledge

Dr. Carol Routledge, Chief Medical & Scientific Officer of

Small Pharma's SPL026 Phase IIa trial data analysis - Dr. Carol Routledge

Small Pharma's SPL026 Phase IIa trial data analysis - Dr. Carol Routledge

Our Chief Medical & Scientific Officer Dr Carol Routledge, discusses some of the key

Small Pharma Takes The Psychedelic Industry By Storm | DMT Innovation Passport, Phase 2 Trial & More

Small Pharma Takes The Psychedelic Industry By Storm | DMT Innovation Passport, Phase 2 Trial & More

Small Pharma

Small Pharma's Big Minds - Ellen James, PhD

Small Pharma's Big Minds - Ellen James, PhD

Ellen James, Director of Research & Development, shares her excitement about the plans for

$PSYC Highlights on Enveric Biosciences

$PSYC Highlights on Enveric Biosciences

Enveric Biosciences announced the closing of its acquisition of MagicMed Industries Inc. ("MagicMed"), a biotechnology company ...

Small Pharma's SPL026 Phase IIa trial update - George Tziras

Small Pharma's SPL026 Phase IIa trial update - George Tziras

Small Pharma's

Related Video Content

Psychology Today: Health, Help, Happiness + Find a Therapist information

Find out the answers to these questions and more with Psychology Today. Many students have compared the happiness of...

Psych (TV Series 2006–2014) - IMDb information

Psych: Created by Steve Franks. With James Roday Rodriguez, Dulé Hill, Timothy Omundson, Corbin Bernsen. When a...

'Psycho' slams seat into tall plane passenger behind him information

May 21, 2026 · Nothing worse than a backseat pile-driver. A United Airlines passenger has been labeled a “psycho”...

APA PsycInfo information

Institutional access to APA PsycInfo provides a single source of vetted, authoritative research for users across the...

Psych - Wikipedia information

Psych premiered on July 7, 2006, following the fifth season premiere of Monk, and continued to be paired with the...